UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain

The Journal of pharmacology and experimental therapeutics, 2006-03, Vol.316 (3), p.1282-1290

2006

Volltextzugriff (PDF)

Pregnancy and neonatal outcomes of COVID‐19: coreporting of common outcomes from PAN‐COVID and AAP‐SONPM registries

Ultrasound in obstetrics & gynecology, 2021-04, Vol.57 (4), p.573-581

2021

Volltextzugriff (PDF)

Microchip databases - the facts

Veterinary Nursing Journal, 2013-10, Vol.28 (10), p.333-335

Hammond, Beverley

2013

Volltextzugriff (PDF)

Effects of the selective 5-HT 7 receptor antagonist SB-269970 in animal models of psychosis and cognition

Behavioural brain research, 2012-03, Vol.228 (1), p.211-218

2012

Volltextzugriff (PDF)

Effects of the selective 5-HT7 receptor antagonist SB-269970 in animal models of psychosis and cognition

Behavioural brain research, 2012-03, Vol.228 (1), p.211-218

2012

Volltextzugriff (PDF)

Abstract 1207: Reversing lactate-driven immunosuppression using the novel, potent and selective MCT4 inhibitor AZD0095

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1207-1207

2019

Volltextzugriff (PDF)

Abstract 4813: Comparative activity profiling of tyrosine kinase inhibitors (TKIs) against exon 20 insertions and the wild-type form of epidermal growth factor receptor (EGFR)

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4813-4813

2019

Volltextzugriff (PDF)

The identification of clinical candidate SB-480848 : A potent inhibitor of lipoprotein-associated phospholipase A2

Bioorganic & medicinal chemistry letters, 2003-03, Vol.13 (6), p.1067-1070

2003

Volltextzugriff (PDF)

The discovery of 6 -[2 -(5 -chloro -2 -{[ (2,4 -difluorophenyl )-methyl ]oxy}phenyl ) -1 -cyclopenten -1 -yl ] -2 -pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain

Bioorganic & medicinal chemistry letters, 2007-01, Vol.17 (2), p.385-389

2007

Volltextzugriff (PDF)

3,4-Dihydro-2H-benzoxazinones are 5-HT1A receptor antagonists with potent 5-HT reuptake inhibitory activity

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (3), p.737-741

2005

Volltextzugriff (PDF)

Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2006-07, Vol.16 (14), p.3657-3662

2006

Volltextzugriff (PDF)

Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition

Behavioural brain research, 2012-03, Vol.228 (1), p.211-218

2012

Volltextzugriff (PDF)

1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists : Structure-activity relationships of 4-and 5-substituted benzoic acid derivatives

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (3), p.732-735

2007

Volltextzugriff (PDF)

1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (4), p.916-920

2007

Volltextzugriff (PDF)

1,5-Biaryl pyrrole derivatives as EP 1 receptor antagonists: Structure–activity relationships of 4- and 5-substituted benzoic acid derivatives

Bioorganic & medicinal chemistry letters, 2007, Vol.17 (3), p.732-735

2007

Volltextzugriff (PDF)

1,5-Biaryl pyrrole derivatives as EP sub(1) receptor antagonists. Structure- activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (4), p.916-920

2007

Volltextzugriff (PDF)

1,5-Biaryl pyrrole derivatives as EP sub(1) receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (3), p.732-735

2007

Volltextzugriff (PDF)

The discovery of SB-435495: A potent, orally active inhibitor of lipoprotein-associated phospholipase A2 for evaluation in man

Bioorganic & medicinal chemistry letters, 2002-09, Vol.12 (18), p.2603-2606

2002

Volltextzugriff (PDF)

1,5-Biaryl pyrrole derivatives as EP 1 receptor antagonists. Structure–activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives

Bioorganic & medicinal chemistry letters, 2007, Vol.17 (4), p.916-920

2007

Volltextzugriff (PDF)

The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP 1 receptor antagonist for the treatment of inflammatory pain

Bioorganic & medicinal chemistry letters, 2007, Vol.17 (2), p.385-389

2007

Volltextzugriff (PDF)

Structure-activity relationships of 1,5-biaryl pyrroles as EP sub(1) receptor antagonists

Bioorganic & medicinal chemistry letters, 2006-07, Vol.16 (14), p.3657-3662

2006

Volltextzugriff (PDF)

Structure–activity relationships of 1,5-biaryl pyrroles as EP 1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2006, Vol.16 (14), p.3657-3662

2006

Volltextzugriff (PDF)

3,4-Dihydro-2H-benzoxazinones are 5-HT(1A) receptor antagonists with potent 5-HT reuptake inhibitory activity

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (3), p.737-741

2005

Volltextzugriff (PDF)

3,4-Dihydro-2 H-benzoxazinones are 5-HT 1A receptor antagonists with potent 5-HT reuptake inhibitory activity

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (3), p.737-741

2005

Volltextzugriff (PDF)

Editorial

Australasian journal of early childhood, 1997-06, Vol.22 (2), p.iii-iv

1997

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(56)
Dissertationen
(1)

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain

Pregnancy and neonatal outcomes of COVID‐19: coreporting of common outcomes from PAN‐COVID and AAP‐SONPM registries

Microchip databases - the facts

Effects of the selective 5-HT 7 receptor antagonist SB-269970 in animal models of psychosis and cognition

Effects of the selective 5-HT7 receptor antagonist SB-269970 in animal models of psychosis and cognition

Abstract 1207: Reversing lactate-driven immunosuppression using the novel, potent and selective MCT4 inhibitor AZD0095

Abstract 4813: Comparative activity profiling of tyrosine kinase inhibitors (TKIs) against exon 20 insertions and the wild-type form of epidermal growth factor receptor (EGFR)

The identification of clinical candidate SB-480848 : A potent inhibitor of lipoprotein-associated phospholipase A2

The discovery of 6 -[2 -(5 -chloro -2 -{[ (2,4 -difluorophenyl )-methyl ]oxy}phenyl ) -1 -cyclopenten -1 -yl ] -2 -pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain

3,4-Dihydro-2H-benzoxazinones are 5-HT1A receptor antagonists with potent 5-HT reuptake inhibitory activity

Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists

Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition

1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists : Structure-activity relationships of 4-and 5-substituted benzoic acid derivatives

1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives

1,5-Biaryl pyrrole derivatives as EP 1 receptor antagonists: Structure–activity relationships of 4- and 5-substituted benzoic acid derivatives

1,5-Biaryl pyrrole derivatives as EP sub(1) receptor antagonists. Structure- activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives

1,5-Biaryl pyrrole derivatives as EP sub(1) receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives

The discovery of SB-435495: A potent, orally active inhibitor of lipoprotein-associated phospholipase A2 for evaluation in man

1,5-Biaryl pyrrole derivatives as EP 1 receptor antagonists. Structure–activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives

The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP 1 receptor antagonist for the treatment of inflammatory pain

Structure-activity relationships of 1,5-biaryl pyrroles as EP sub(1) receptor antagonists

Structure–activity relationships of 1,5-biaryl pyrroles as EP 1 receptor antagonists

3,4-Dihydro-2H-benzoxazinones are 5-HT(1A) receptor antagonists with potent 5-HT reuptake inhibitory activity

3,4-Dihydro-2 H-benzoxazinones are 5-HT 1A receptor antagonists with potent 5-HT reuptake inhibitory activity

Editorial

Suchergebnisse filtern